Cargando…
TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis
Despite advances in treatment modalities, 5-year survival among glioma patients remains poor. Glioma cancer stem cells (CSCs) exhibit high tumorigenic activity and are associated with resistance to treatment and tumor recurrence. Because overexpression of toll-like receptor 4 (TLR4) correlated with...
Autores principales: | Che, Fengyuan, Yin, Jiawei, Quan, Yanchun, Xie, Xiaoli, Heng, Xueyuan, Du, Yifeng, Wang, Lijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581125/ https://www.ncbi.nlm.nih.gov/pubmed/28881826 http://dx.doi.org/10.18632/oncotarget.18586 |
Ejemplares similares
-
Potential Epigenetic-Based Therapeutic Targets for Glioma
por: Zang, Lanlan, et al.
Publicado: (2018) -
LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4
por: Han, Sheng, et al.
Publicado: (2017) -
RAB42 Promotes Glioma Pathogenesis via the VEGF Signaling Pathway
por: Liu, Baoling, et al.
Publicado: (2021) -
Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
por: Liu, Baoling, et al.
Publicado: (2022) -
Sequential responses of mouse spleen T cells in mixed lymphocyte culture-induced cytolysis
Publicado: (1975)